01
What Is Microneedle Drug Delivery?
Microneedles create micron-scale pathways through the stratum corneum to enable transdermal or intradermal delivery while avoiding the pain and usability limitations associated with conventional injections.
A development platform from delivery-route innovation to scale-up
Microneedle Drug Formulation CRO/CDMO
End-to-end development support for microneedle drug products, from feasibility and formulation to pilot scale-up, clinical batches and commercialization.02
Suitable Modalities and Applications
The platform can evaluate innovative and improved drug products across multiple therapeutic areas and payload classes.
- Metabolic medicines, including GLP-1-related programs
- Local anesthetics and pain-management products
- Neurology and sleep-related small molecules
- Dermatology and local anti-inflammatory products
- Peptides, proteins and nucleic-acid payloads
- Intradermal vaccine delivery
03
CRO/CDMO Development Workflow
Feasibility assessment → formulation development → process development → preclinical support → pilot scale-up → clinical-batch preparation → IND-support documentation → commercial manufacturing support.
04
Evaluation and Quality Capabilities
Available methods include microneedle morphology, insertion and mechanical testing, HPLC analysis, stability studies, and release or permeation evaluation using IVRT/IVPT approaches.
05
How to Start a Project
A project normally begins with the active ingredient, target dose, intended application, development stage and expected regulatory pathway. CASMN then proposes a feasibility and development plan.
Discuss a Microneedle Drug Project
Send your target product, payload, development stage and cooperation scope to our business development team.
Email bd@casmn.com